BALA CYNWYD, Pa., Dec. 13, 2013 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Insys Therapeutics, Inc. ("Insys" or the "Company") (Nasdaq: INSY).
Click here to learn more http://brodsky-smith.com/686-insy-insys-therapeutics-inc.html, or call: 877-534-2590. There is no cost or obligation to you.
The investigation is related to the Company's December 12, 2013, disclosure that the Company has received a subpoena from the office of Inspector General of the Department of Health and Human Services regarding the Company's sales and marketing practices of Subsys, a proprietary sublingual fentanyl spray for the treatment of pain related in opioid-tolerant cancer patients. Following this announcement shares of Insys fell approximately 29%.
If you own shares of Insys common stock and wish to discuss the investigation and its findings, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at firstname.lastname@example.org, or by visiting http://brodsky-smith.com/686-insy-insys-therapeutics-inc.html, or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and case action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
SOURCE Brodsky & Smith, LLC